SHL Medical, a world-leading solutions provider of advanced drug delivery systems and SteriPack Group, renowned global supplier of secondary packing and final assembly services to the pharmaceutical industry, enter a non-exclusive strategic partnership.
FUJIFILM Diosynth Biotechnologies, a world-leading contract development and manufacturing organization (CDMO) for biologics, vaccines, advanced therapies and oncolytic viruses enters a non-exclusive strategic partnership agreement with SHL Medical (SHL), a world-leading solutions provider of advanced drug delivery systems.
Visit Booth #D60 during Pharmapack Europe 2024 on January 24-25 and learn about SHL Medical’s Molly® Connected Cap, Innovation Partnership, and more!
The Science Based Targets initiative (SBTi) has approved SHL Medical’s near-term science-based emissions reduction target, underlining the company’s dedication to remaining transparent and accountable throughout its entire sustainability journey.
The Science Based Targets initiative (SBTi) has approved SHL Medical’s near-term science-based emissions reduction target, underlining the company’s dedication to remaining transparent and accountable throughout its entire sustainability journey.
SHL held several blood donation drives at different Taiwan office sites in June, collecting near 120 units of blood in total.
On November 5, SHL Group, a global leader in the design, development, and manufacturing of drug delivery devices, held the inauguration of its new Liufu site in Taoyuan City, Taiwan.
SHL is set on presenting its strong pipeline of autoinjectors designed for high volume and high viscosity drug formulations.
SHL Group announced plans to create 800 new jobs in Taiwan to support ramped up productions for SHL Medical.
Update your browser to view this website correctly. Update my browser now
